Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Influenza Vaccine (Split Virion), Inactivated, Quadrivalent
BIOLOGICAL
3 trials
Sponsors
Sinovac Biotech Co., Ltd
, Hualan Biological Bacterin Co. Ltd.
, Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Conditions
GCP
Influenza, Human
Seasonal Influenza
Phase 1
Clinical Trials of Quadrivalent Influenza Vaccine
Recruiting
NCT06824519
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Influenza, Human
Start: 2025-05-08
End: 2026-09-01
Target: 620
Updated: 2026-05-05
Phase 3
Immunogenicity and Safety Study of Influenza Vaccine (Split Virion), Inactivated, Quadrivalent
Completed
NCT05431725
Sinovac Biotech Co., Ltd
Seasonal Influenza
Start: 2022-07-18
End: 2023-07-19
Updated: 2024-05-28
Unknown Phase
Exploration on the Quadrivalent Influenza Vaccine Immunization Schedule for Children Aged 3-8 Years
Completed
NCT06095947
Hualan Biological Bacterin Co. Ltd.
GCP
Start: 2021-09-15
End: 2023-02-28
Updated: 2025-09-15
Related Papers
Influenza vaccines promote humoral and cellular immune responses: a randomized, double-blind, phase 3 trial.
2025-12-07